Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.75
Bid: 12.50
Ask: 13.00
Change: -0.05 (-0.39%)
Spread: 0.50 (4.00%)
Open: 12.80
High: 12.75
Low: 12.55
Prev. Close: 12.75
POLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Secure Trust lending up; Eurocell sales climb

Thu, 12th May 2022 15:35

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Secure Trust Bank PLC - Solihull, England-based savings accounts and lending services provider - New business lending rises 3.6% quarter-on-quarter to GBP488.2 million in first quarter. Annually, business lending volumes rise 53% from GBP318.5 million. "Record new business volumes have been delivered for successive quarters in both the Vehicle Finance and Retail Finance businesses," Secure Trust says. Core loan book rises 19% annually to USD2.57 billion, up 4.8% from fourth quarter of 2021. "Customer deposits were 4.1% higher at the end of the quarter, in line with loan book growth. The group's strong liquidity position reflects a pre-funding approach for the lending pipeline," Secure Trust says.

----------

Eurocell PLC - Derbyshire-based window, door and roofline PVC products maker - Says group sales in first four months of 2022 up 13% year-on-year, rising 39% from 2019 levels. Eurocell says: "The repair, maintenance and improvement market remains robust and we have kept pace with an exceptionally strong comparative period. Current indications are that RMI demand includes a greater emphasis on project-specific work, rather than the higher levels of maintenance activity experienced last year. We believe we are continuing to take market share and have made substantial progress compared to the equivalent period of 2019." Company names Derek Mapp as non-executive director and chair designate with effect May 16. Following handover, he takes over as chair from July 1, at which point Bob Lawson will retire. Mapp is also chair of Mitie Group PLC.

----------

Ideagen PLC - Nottingham-based information management, safety, risk and compliance software provider - Expects revenue for year ended April 30 to rise 41% year-on-year to GBP92.2 million from GBP65.6 million. Adjusted earnings before interest, tax, depreciation and amortisation to climb by a third to GBP30.5 million from GBP22.9 million.

----------

Mirada PLC - Surrey, England-based broadcasting technology firm - Says trading in year ended March 31 was in line with market expectations. Expects revenue of USD11 million, down a touch from USD11.1 million. Adjusted earnings before interest, tax, depreciation and amortisation edge down to USD1.6 million from USD1.7 million. Mirada says: "The directors believe that to deliver this performance despite virtually no new business activity taking place across the industry for the first half of the year, is testament to the resilience of Mirada's model and the strength of the relationships the company has with its customers, with many deepening their commercial agreements in the period."

----------

Kape Technologies PLC - Isle of Man-based digital security and privacy software provider - Says number of firm's privacy brands have expanded platforms, adding "several new features". Kape adds: "The launch of a number of highly innovative new products, in addition to enhanced features on existing solutions, is closely aligned with significant demand across the digital privacy sector. With the cybersecurity sector delivering its strongest quarter on quarter growth to-date, Kape continues to be firmly focused on delivering best-in-class privacy and security solutions that safeguard consumers' digital lives." Kape's ExpressVPN product adds online threat manager service, password manager and parallel connections offering to provide "speediest re-connection when moving between different networks".

----------

H&T Group PLC - Surrey, England-based pawnbroker - Says demand for pledge lending at record levels. H&T's pawnbroking pledge book grows to GBP78.3 million at end of April from GBP66.9 million at December 31. Also seeing "strong" demand for new and pre-owned jewellery and watches, with retail sales in line with "management expectations and very significantly ahead of the prior year". H&T adds: "[The] foreign exchange performance is recovering quickly as customers return to overseas holidays. Transaction volumes in recent weeks have returned to pre-pandemic levels and are expected to build further over the summer months. H&T will enhance its FX offering ahead of the peak summer period, including the re-introduction of an online service."

----------

FBD Holdings PLC - Dublin-based insurance company - Ahead of annual general meeting on Thursday, Chief Executive Tomas Midheach says firm's underwriting performance so far in 2022 has been in line with expectations. "While inflation continues to be experienced in property and motor damage claims, injury claims experience has been benign and there were no significant weather events," he says. Gross written premiums up 1% annually to date, after adjusting for the prior year's Covid-19 related premium rebates. However, "investment markets have been difficult year to date", Midheach says. On Covid-19 business interruption claims for its pub policies, FBD says provisions remain at EUR44 million. CEO adds: "We are engaging with the plaintiffs on the steps needed to bring final clarity for all concerned."

----------

Empresaria Group PLC - Crawley, West Sussex-based specialist staffing - Makes "encouraging start" to 2022, with "strong" growth in net fee income. On track to meet market expectations for 2022.

----------

Seraphim Space Investment Trust PLC - London-based investor in space technology - Says net asset value per share weakens 1.0% quarter-on quarter to 105 pence at March 31 third quarter end, from 104p. Company says this is "driven by the impact of weak equity markets on the value of listed portfolio companies".

----------

Various Eateries PLC - London-based chain of restaurants, clubhouses and hotels such as Coppa Club - Says trading in first half ended April 3 was robust, save for duration of Covid-19 plan B curbs made to stem spread of Omicron variant in UK. Revenue during half jumps more than five-fold to GBP17.8 million from GBP3.3 million a year prior, "driven by new site openings and reflecting fewer restricted periods of trading". Company adds: "Since 'Plan B' restrictions were lifted in January 2022, overall trading steadily recovered and has been in line with management expectations, despite various macro uncertainties." "The group is conscious that the industry-wide challenges currently faced, including labour shortages and increasing inflation, have heightened uncertainty. However, with a management team who have seen many periods of uncertainty before, the group is confident in its ability to successfully navigate the challenges while continuing to pursue its exciting growth strategy."

----------

Abingdon Health PLC - York, England-based rapid test developer and manufacturer - Teams with biomedical laboratory services provider Bimelix Ab for development of Lyme disease lateral flow self-test. "Abingdon and Bimelix have been collaborating for over 12 months on the feasibility of developing a Lyme disease LFT self-test. Under the terms of the agreement, Abingdon and Bimelix will jointly complete the development of the Lyme disease test and scale-up to manufacture, and will also be jointly responsible for the commercialisation of the test," Abingdon says.

----------

Poolbeg Pharma PLC - London-based pharmaceutical company - Signs GMP manufacturing deal to ensure "ample supply" of POLB 001 asset, which aims to address a significant unmet need in severe influenza. Asset will be used in the upcoming human challenge clinical trial due to start next month.

----------

Panther Metals PLC - mineral exploration in Canada - Reports update on Coglia nickel and cobalt project drilling work, following initial announcement by 37%-owned Panther Metals Ltd. Final assay results show "highest-grade intercepts of nickel and cobalt" across whole drill programme at the Western Australia-located asset. Panther Metals Ltd Managing Director Daniel Tuffin says work for mineral resource estimate begins immediately.

----------

Wishbone Gold PLC - Gibraltar-based precious metals trading and exploration company - Says heritage survey underway at Red Setter copper and gold project in Western Australia. "The aim of this survey is to increase access to peripheral targets, beyond those already cleared, where drilling will start in the next few weeks," Wishbone says.

----------

Caledonia Mining Corp PLC - gold producer with operations in Zimbabwe - Says revenue in first quarter of 2022 increases 36% to USD35.1 million from USD25.7 million. Pretax profit rises 46% to GBP12.5 million from GBP8.5 million. Says gold output rises 40% to 18,515 ounces from 13,197 ounces a year prior.

----------

Artemis Resources Ltd - Perth-based miner with gold, copper and cobalt projects in Australia - Completes heritage survey at Osborne nickel prospect, which is subject to farm-in joint venture with GreenTech Metals Ltd. GreenTech plans six drill holes. "This programme is anticipated to commence in June following receipt of the heritage clearance report," Artemis adds.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 Jul 2022 12:04

IN BRIEF: Poolbeg Pharma shares rise as first human trial begins

Poolbeg Pharma PLC - London-based pharmaceutical company - Receives approval to commence its Lipopolysaccharide human clinical trial for POLB 011, a drug that aims to treat severe influenza. The trial will formally start on Friday. It will assess POLB 011 in damping the immune response to lipopolysaccharide, which acts as a surrogate for the hyperinflammatory response associated with severe influenza. Initial results are expected in the final quarter of 2022. Poolbeg says at that point it intends to "rapidly" monetise by out-licensing and/or partnering with pharmaceutical and biotechnology companies for the drug's further development.

Read more
27 Jun 2022 10:47

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis

(Alliance News) - Poolbeg Pharma PLC on Monday said its build and optimisation of an artificial intelligence model of respiratory syncytial virus data is complete.

Read more
27 May 2022 10:43

AIM WINNERS & LOSERS: Premier Miton advances; Advance Energy retreats

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
26 May 2022 16:54

IN BRIEF: Poolbeg Pharma shares soar on US patent grants

Poolbeg Pharma PLC - London-based pharmaceutical company - Wins patent grants from the US Patent & Trademark Office for its POLB 001 and POLB 002 molecules. The former is used to treat influenza, while the latter is an RNA-based immunotherapy for respiratory virus infections. "The company is continuing working with its patent advisors to broaden and expand the POLB 001 and POLB 002 patent families," Poolbeg says.

Read more
26 May 2022 10:51

AIM WINNERS & LOSERS: Poolbeg wins patents; RA swings to loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
27 Apr 2022 20:15

IN BRIEF: Poolbeg hails shareholder confidence as lock-up period ends

Poolbeg Pharma PLC - London-based pharmaceutical company - Confirms proposals have been accepted by distribution in specie shareholders seeking to sell a total of GBP366,000 of Poolbeg shares, representing only 3% of the distribution in specie shares. Says 97% of distribution in specie shareholders have decided to remain invested in Poolbeg following the end of the lock-up period.

Read more
14 Apr 2022 21:36

TRADING UPDATES: Polar Capital assets up; Brooks Macdonald funds fall

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
14 Apr 2022 14:53

Poolbeg granted European patent for antiviral nose spray

(Sharecast News) - Clinical-stage pharmaceutical company Poolbeg Pharma reported on the strengthening of its intellectual property (IP) for its 'POLB 002' asset on Thursday - a first-in-class, intranasally-administered RNA-based immunotherapy for respiratory virus infections.

Read more
13 Apr 2022 19:46

TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
11 Apr 2022 21:58

TRADING UPDATES: TruFin raises GBP10 million, Afentra preferred bidder

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Apr 2022 10:57

AIM WINNERS & LOSERS: Mothercare misses payment; Argos licence renewed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
31 Mar 2022 21:07

TRADING UPDATES: SSE's Transmission raises cash; Croda gets UK grant

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
30 Mar 2022 19:25

IN BRIEF: Poolbeg Pharma starts trading on OTCQB Venture Market

Poolbeg Pharma PLC - London-based pharmaceutical company - Shares start trading on the OTCQB Venture Market in the US.

Read more
28 Mar 2022 15:10

UK shareholder meetings calendar - next 7 days

Tuesday 29 March 
Impax Asset Management Group PLCAGM
Tekmar Group PLCAGM
Wednesday 30 March 
Brunner Investment Trust PLCAGM
Mediazest PLCAGM
Micro Focus International PLCAGM
Parsley Box Group PLCGM re equity raise
Power Metal Resources PLCGM re carried forward losses
Power Metal Resources PLCAGM
Thursday 31 March 
Pressure Technologies PLCAGM
Red Rock Resources PLCAGM
Aukett Swanke Group PLCAGM
Various Eateries PLCAGM
Toople PLCAGM
BiVictriX Therapeutics PLCAGM
CloudCoCo Group PLCAGM
Friday 1 April 
Gfinity PLCGM re fundraising
River & Mercantile Group PLCAGM
Monday 4 April 
Poolbeg Pharma PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.